Intratumoral PKM2 expression predicts benefit from adjuvant FOLFOX in stage II-III colorectal cancer.

J Gastrointest Oncol · 2026 · PMC13188001 · PMID 42169878

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP=0.08so close (0.05 < p ≤ 0.1)

6.3%), although the difference did not reach statistical significance (P=0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.